Report cover image

PTA Peripheral DCB Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022

Publisher GlobalData
Published Mar 17, 2022
Length 102 Pages
SKU # GBDT17166105

Description

PTA Peripheral DCB Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022

Summary

GlobalData's Medical Devices sector report, “PTA Peripheral DCB Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 provides comprehensive information about the PTA Peripheral DCB Catheters pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

A PTA Peripheral DCB Catheter is a drug-coated percutaneous transluminal angioplasty (PTA) balloon intended to prevent restenosis, or restenosis of the peripheral arteries.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the PTA Peripheral DCB Catheters under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of PTA Peripheral DCB Catheters and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to

Formulate significant competitor information, analysis, and insights to improve R&D strategies- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage- Identify and understand important and diverse types of PTA Peripheral DCB Catheters under development- Develop market-entry and market expansion strategies- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

102 Pages
  • About GlobalData
    • PTA Peripheral DCB Catheters Overview
    • PTA Peripheral DCB Catheters - Pipeline Products by Stage of Development
    • PTA Peripheral DCB Catheters - Pipeline Products by Territory
    • PTA Peripheral DCB Catheters - Pipeline Products by Regulatory Path
    • PTA Peripheral DCB Catheters - Pipeline Products by Estimated Approval Date
    • PTA Peripheral DCB Catheters - Ongoing Clinical Trials
    • PTA Peripheral DCB Catheters Companies - Pipeline Products by Stage of Development
    • PTA Peripheral DCB Catheters - Companies Pipeline Products by Stage of Development
    • AnGes Inc Company Overview
    • AngioCure, Inc. Company Overview
    • Ascenion GmbH Company Overview
    • Boston Scientific Corp Company Overview
    • Cardionovum GmbH Company Overview
    • Chansu Vascular Technologies LLC Company Overview
    • Concept Medical Inc Company Overview
    • Contego Medical LLC Company Overview
    • eucatech AG Company Overview
    • Genesis MedTech International Pvt Ltd Company Overview
    • Lifetech Scientific (Shenzhen) Co Ltd Company Overview
    • Lutonix Inc Company Overview
    • M.A. Med Alliance SA Company Overview
    • Medtronic Plc Company Overview
    • Micell Technologies Inc Company Overview
    • OrbusNeich Company Overview
    • Orchestra BioMed Inc Company Overview
    • Pulsus Medical LLC (Inactive) Company Overview
    • QualiMed Innovative Medizinprodukte GmbH Company Overview
    • Shenzhen Salubris Pharmaceuticals Co Ltd Company Overview
    • SiL Vascular Ltd Company Overview
    • Spectranetics Corp Company Overview
    • Stemplant LLC Company Overview
    • SurModics Inc Company Overview
    • Tailored Medical Devices Inc Company Overview
    • TransMed7 LLC Company Overview
    • Vascular Nanotransfer Technologies Company Overview
    • Zylox-Tonbridge Medical Technology Co Ltd Company Overview
    • Feb 10, 2022: Contego Medical Announces Hiring of Steve MacKinnon, Chief Commercialization Officer
    • Jan 13, 2022: QT Vascular Announces Appointment of Mr Thomas Tan Gim Chua as Chief Executive Officer and Executive Director
    • Jan 13, 2022: Qt Vascular Announces Appointment of Chief Operating Officer (Dental)
    • Jan 04, 2022: Medtronic Chairman and CEO Geoff Martha to speak at J.P. Morgan healthcare conference
    • Dec 08, 2021: Dr Jens von Lackum appointed to the Management Board of B. Braun SE
    • Nov 11, 2021: QT Vascular Reports Third Quarter Results For the Period 30 September 2021
    • Nov 11, 2021: Qt Vascular Announces Third Quarter Results
    • Nov 08, 2021: Boston Scientific Announces Upcoming Conference Schedule
    • Nov 04, 2021: Terumo Corp Half Yearly Results For the Period 30 September 2021
    • Oct 27, 2021: Boston Scientific Announces Results For Third Quarter 2021
    • Oct 13, 2021: QT Vascular Announces Appointment of Executive Director
    • Sep 09, 2021: Boston Scientific Announces 2021 Investor Day Meeting
    • Aug 13, 2021: QT Vascular Announces Condensed Interim Financial Statements for the six months ended 30 June 2021
    • Aug 04, 2021: Terumo Revises its Full-Year Financial Guidance for FY2021
    • Aug 04, 2021: Terumo Corp. Announces Consolidated Financial Results for the First Quarter Ended June 30, 2021
    • Jul 30, 2021: QT Vascular Announces Appointment of Independent Director
    • Jul 27, 2021: Cardiovascular Systems to Attend Three Investor Conferences in August
    • Jul 27, 2021: Surmodics to Webcast Third Quarter Fiscal 2021 Earnings Conference Call on August 4
    • Jun 30, 2021: B. Braun Announces Jennifer Prioleau as New Chief Legal Officer and Chief Compliance Officer
    • May 24, 2021: Boston Scientific to Participate in Bernstein's 37th Annual Strategic Decisions Conference
    • Apr 30, 2021: QT Vascular Announces Results of Annual General Meeting Held on 30 April 2021
    • Apr 30, 2021: Qt Vascular Notice of Annual General Meeting
    • Apr 15, 2021: Qt Vascular announces Annual General Meeting
    • Mar 26, 2021: Qt Vascular announce Financial Statements
    • Mar 24, 2021: Cardiovascular Systems to Participate at the 20th Annual Needham Healthcare Conference
    • Mar 22, 2021: Terumo and Allied Telesis jointly develop a smooth operating environment for infusion systems
    • Methodology
    • About GlobalData
    • Contact Us
    • Disclaimer

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us